Olanzapine administered with lithium or valproate resulted in increased levels (≥ 10%) of tremor, dry mouth, increased appetite, and weight gain.
La olanzapina administrada junto con litio o valproato dio lugar a una mayor incidencia (≥ 10%) de temblor, sequedad de boca, aumento del apetito y aumento de peso.